Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: The perspective of eight Ontario hospitals

Canadian Journal of Surgery

Volumn 45, Issue 2, 2002, Pages 132-140

  Graham, Ian D ^a   Alvarez, Gonzalo ^a   Tetroe, Jacqueline ^a   McAuley, Laura ^a   Laupacis, Andreas ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD SUBSTITUTE; DESMOPRESSIN; ERYTHROPOIETIN; HEMOSTATIC AGENT; TRANEXAMIC ACID;

ARTICLE; BLOOD SUBSTITUTION; CANADA; COST BENEFIT ANALYSIS; HOSPITAL; HUMAN; TECHNOLOGY; TREATMENT OUTCOME;

BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; HOSPITALS; HUMANS; INTERVIEWS; ONTARIO;

EID: 0036244771     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Preoperative autologous donation decreases allogeneic transfusion but increases exposure to all red blood cell transfusion: Results of a meta-analysis
2. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion
3. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery
4. Drugs to minimize perioperative blood loss in cardiac surgery: Meta-analyses using perioperative blood transfusion as the outcome
5. Erythropoietin to minimize perioperative blood transfusion: A systematic review of randomized trials
6. Pharmacological strategies to decrease excessive blood loss in cardiac surgery: A meta-analysis of clinically relevant endpoints
7. Is epsilonaminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: A meta-analysis
8. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery
9. Cost of allogeneic and autologous blood transfusion in Canada
10. Intraoperative salvage in patients undergoing elective abdominal aortic aneurysm repair: An analysis of cost and benefit
11. Cell saver and radical retropubic prostatectomy: Analysis of cost-effectiveness
12. Consensus statement: Using epoetin alfa to decrease the risk of allogeneic blood transfusion in surgical setting
13. Adverse effects of methods for minimizing perioperative allogeneic transfusion: A critical review of the literature
14. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: A meta-analysis of unconfounded studies
15. The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals
16. Sampling in qualitative inquiry
17. Toward a comprehensive interdisciplinary model of health care research use
18. How you look determines what you find: Severity of illness and variation in blood transfusion for hip fracture
19. Variation in the use of red blood cell transfusions. A study of four common medical and surgical conditions
20. The variability of transfusion practice in coronary artery bypass surgery